share_log

Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results

Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results

波士頓科學宣佈召開電話會議,討論2024年第二季度業績。
波士頓科學 ·  07/01 00:00

MARLBOROUGH, Mass., July 1, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the second quarter on July 24 prior to the conference call.

2024年7月1日,馬爾伯勒——波士頓科學公司(紐交所:BSX)將在2024年7月24日週三上午8:00(美國東部時間)舉行電話會議,討論截至2024年6月30日的第二季度財務業績和業務亮點。電話會議將由主席兼首席執行官Mike Mahoney和執行副總裁兼首席財務官Dan Brennan主持。公司將在電話會議前於7月24日公佈第二季度財務業績的新聞稿。PRNewswire公司將於7月24日發佈財務業績的新聞稿, 資訊還將以線上形式播放,播放時間將於美國東部時間8點上午開始。 會議由Mike Mahoney和Dan Brennan主持。

A live webcast and replay of the webcast will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

可通過htts://investors.bostonscientific.com進行在線觀看和回放,在活動結束後約一小時後回放服務即可使用。htts://investors.bostonscientific.com活動結束後大約一小時後可以使用回放服務。

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.

關於波士頓科學
科學波士頓公司通過創新的醫療技術改善全球患者的健康,已是全球醫療科技領域的領導者40餘年,提供一系列高性能的方案來解決未滿足的患者需求和降低醫療成本。我們的設備和治療方案幫助醫生診斷和治療複雜的心血管、呼吸、消化、腫瘤、神經和泌尿系統疾病和病症。了解更多信息,請訪問www.bostonscientific.com,並關注領英(曾用名Twitter)和框架。有關詳細信息,請參閱UBS集團報酬報告X

CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com

聯繫方式:
Chanel Hastings
媒體關係
+1 (508) 382-0288
Chanel.Hastings@bsci.com

Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com

Jon Monson
投資者關係
+1 (508) 683-5450
BSXInvestorRelations@bsci.com

SOURCE Boston Scientific Corporation

波士頓科學公司

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論